References

References

1. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989; 12: 553-64.

2. Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944-48.

3. Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med 1999; 61: 712-28.

4. Cott JM, Fugh-Berman A. Is St John's Wort (Hypericum perforatum) an effective antidepressant? J Nerv Ment Dis 1998; 186: 500-01.

5. Deahl M. Betel nut-induced extrapyramidal syndrome: an unusual drug interaction. Mov Disord 1989; 4: 330-33.

6. Taylor RFH, Al-Jarad N, John LME. Betel-nut chewing and asthma. Lancet 1992; 339: 1134-36.

7. Hakas JF. Topical capsaicin induces cough in patient receiving ACE inhibitor. Ann Allergy 1990; 65: 322.

8. Bouraoui A, Toum A, Bouchoucha S, et al. Influence de l'alimentation épicéé et piquante sur l'absorption de la théophylline. Thérapie 1986; 41: 467-71.

9. Tam LS, Chan TYK, Leung WK, Critchley JAJH. Warfarin interactions with Chinese traditional medicines; danshen and methyl salicylate medicated oil. Aust NZ J Med 1995; 25: 257.

10. Yu CM, Chan JCN, Sanderson JE. Chinese herbs and warfarin potentiation by 'danshen'. J Intern Med 1997; 241: 337-39.

11. Izzat MB, Yim APC, El-Zufari MH. A taste of Chinese medicine. Ann Thorac Surg 1998; 66: 941-42.

12. Chan K, Lo AC, Yeung JH, Woo KS. The effects of danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats. J Pharm Pharmacol 1995; 47: 402-06.

13. Cheng TO. Warfarin danshen interaction. Ann Thorac Surg 1999; 67: 892-96.

14. Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a five year toxicological study (1991-1995). Drug Saf 1997; 17: 342-56.

15. Page RL, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy 1999; 19: 870-76.

16. Ellis GR, Stephens MR. Untitled (photograph and brief case report). BMJ 1999; 319: 650.

17. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996; 155: 293-95.

18. De Smet PAGM, D'Arcy PF. Drug interactions with herbal and other non-toxic remedies. In: D'Arcy PF, McElnay JC, Welling PG, eds. Mechanisms of drug interactions. Berlin: Springer-Verlag, 1996.

19. Burnham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconstruc Surg 1995; 95: 213.

20. German K, Kumar U, Blackford HN. Garlic and the risk of TURP bleeding. Br J Urol 1995; 76: 518.

21. Rose KD, Croissant PD, Parliament CF, Levin MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic consumption: a case report. Neurosurgery 1990; 26: 880-82.

22. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract. N Engl J Med 1997; 336: 1108.

23. Lamant V, Mauco G, Braquet P, Chap H, Douste-Blazy L. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol 1987; 36: 2749-52.

24. Chung KF, McCusker M, Page CP, et al. Effect of a ginkgolide mixture (BN 52063) in antagonizing skin and platelet responses to platelet activating factor in man. Lancet 1987; i: 248-50.

25. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46: 1775-76.

26. Vale S. Subarachnoid haemorrhage associated with ginkgo biloba. Lancet 1998; 352: 36.

27. Gilbert GJ. Ginkgo biloba. Neurology 1997; 48: 1137.

28. Matthews MK. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998; 50: 1933.

29. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997; 54: 692-93.

30. Zhu M, Chan KW, Ng LS, et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 1999; 51: 175-80.

31. Shader RI, Greenblatt DJ. Phenelzine and the dream machine--ramblings and reflections. J Clin Psychopharmacol 1985; 5: 65.

32. Jones BD, Runikis AM. Interaction of ginseng with phenelzine. J Clin Psychopharmacol 1987; 7: 201-02.

33. Lee FC, Ko JH, Park JK, Lee JS. Effects of Panax ginseng on blood alcohol clearance in man. Clin Exp Pharmacol Physiol 1987; 14: 543-46.

34. Aslam M, Stockley IH. Interaction between curry ingredient (karela) and drug (chlorpropamide). Lancet 1979; i: 607.

35. Leatherdale BA, Panesar RK, Singh G, et al. Improvement in glucose tolerance due to Momordica charantia (karela). BMJ 1981; 282: 1823-24.

36. Chen M-F, Shimada F, Kato H, et al. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Endocrinol Jpn 1991; 38: 167-75.

37. Chen M-F, Shimada F, Kato H, et al. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate. Endocrinol Jpn 1990; 37: 331-41.

38. Teelucksingh S, Mackie ADR, Burt D, et al. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 1990; 335: 1060-63.

39. De Klerk GJ, Nieuwenhuis MG, Beutle JJ. Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum. BMJ 1997; 314: 731-32.

40. Bernardi M, D'Intino PE, Trevisani F, et al. Effects of prolonged graded doses of licorice by healthy volunteers. Life Sci 1994; 55: 863-72.

41. Perlman BB. Interaction between lithium salts and ispaghula husk. Lancet 1990; 335: 416.

42. Gordon JB. SSRIs and St John's wort: possible toxicity? Am Fam Phys 1998; 57: 950.

43. Demott K. St John's wort tied to serotonin syndrome. Clin Psychiatry News 1998; 26: 28.

44. Lantz MS, Buchalter E, Giambanco V. St John's Wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatr Neurol 1999; 12: 7-10.

45. Nebel A, Schneider BJ, Baker RK, Kroll DJ. Potential metabolic interaction between St John's Wort and theophylline. Ann Pharmacother 1999; 33: 502.

46. Johne A, Brockmöller J, Bauer S, et al. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66: 338-45.

47. Ernst E. Second thoughts about safety of St John's wort. Lancet 1999; 354: 2014-15.

48. Maurer A, Johne A, Bauer S, et al. Interaction of St John's wort extract with phenprocoumon. Eur J Clin Pharmacol 1999; 55: A22.

49. Bon S, Hartmann K, Kuhn M. Schweitzer Apothekerzeitung 1999; 16: 535-36.

50. Homma M, Oka K, Ikeshima K, et al. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol 1995; 47: 687-92.

51. Dandekar UP, Chandra RS, Dalvi S, et al. Analysis of clinically important interaction between phenytoin and Shankhapushpi, an Ayurvedic preparation. J Ethnopharm 1992; 35: 285-88.

52. Mustapha A, Yakasai IA, Aguye IA. Effect of Tamarindus indica L on the bioavailability of aspirin in healthy human volunteers. Eur Drug Metab Pharmacokinet 1996; 21: 223-26.

53. Bos R, Woerdenberg HJ, De Smet PAGM, Scheffer JJC. Valeriana species. In: De Smet PAGM, Keller K, Hansel R, Chandler RF, eds. Adverse effects of herbal drugs, vol 3. Berlin: Springer, 1997: 165-80.

54. Lacombiez L, Bensimon G, Isnard F, et al. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypertension induced by clomipramine. Clin Pharmacol Ther 1989; 45: 241-51.

55. De Smet PAGM. Yohimbe alkaloids--general discussion. In: De Smet PAGM, Keller K, Hansel R. Chandler RF, eds. Adverse effects of herbal drugs, volume 3. Berlin: Springer, 1997: 181-206.

56. But PP-H. Herbal poisoning caused by adulterants or erroneous substitutes. J Trop Med Hyg 1994; 97: 371-74.

57. Koren G, Randor S, Martin S, Danneman D. Maternal ginseng use associated with neonatal androgenization. JAMA 1990; 264: 2866.

58. Awang DVC. Maternal use of ginseng and neonatal androgenization. JAMA 1991; 266: 363.

59. Huang WF, Wen K-C, Hsiao M-L. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997; 37: 344-50.

60. Gertner E, Marshall PS, Filandrinos D, et al. Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum 1995; 38: 614-17.

61. Vander Stricht BI, Parvais OE, Vanhaelen-Fastre RJ. Remedies may contain cocktail of active drugs. BMJ 1994; 308: 1162.

62. Ko RJ. Adulterants in Asian patent medicines. N Engl J Med 1998; 339: 847.

63. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-97. JAMA 1998; 280: 1569-75. 64. Barnes J, Mills SY, Abbott NC, et al. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face to face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 1998; 45: 496-500.

65. Westendorf J. Anthranoid derivatives--general discussion. In: De Smet PAGM, Keller K, Hansel R, Chandler RF. Adverse effects of herbal drugs, vol 2: 105-08.

Remember we are NOT Doctors and have NO medical training.

This site is like an Encylopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.